Bristol Myers Squibb (NYSE: BMY) has announced positive topline results from the Phase 2 TRANSCEND FL trial, evaluating Breyanzi® (lisocabtagene maraleucel) in adult patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma. The study met its primary endpoint in the…
Levi & Korsinsky, LLP Announces Securities Fraud Lawsuit Against Regeneron Pharmaceuticals, Inc. Levi & Korsinsky, LLP has issued a notice to investors in Regeneron Pharmaceuticals the regarding a class action lawsuit filed against the Company. This lawsuit aims to recover…
Prolong Pharmaceuticals to Present Preliminary Phase 1 Data for PP-007 in AIS at 2025 ISC Phase 1 Data Prolong Pharmaceuticals, LLC, a clinical-stage biopharmaceutical company, is poised to make a significant contribution to the field of acute ischemic stroke (AIS)…
LEO Pharma Reports Positive DELTA TEEN Results for Anzupgo® in Adolescent CHE LEO Pharma Reports A/S, a global leader in medical dermatology, has announced the successful completion of its DELTA TEEN trial, a pivotal phase 3 clinical study evaluating Anzupgo®…
United Therapeutics Announces Full Enrollment in TETON 1 Study of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis Inhaled Treprostinil United Therapeutics Corporation a public benefit corporation, recently announced the completion of full enrollment in its pivotal TETON 1 clinical study. This…
Bridging the Breast Cancer Awareness Gap: Insights from a Pan-European Survey A newly released survey, sponsored by Daiichi Sankyo and AstraZeneca, underscores the urgent need for more accessible and accurate information about breast cancer. Conducted across five major European countries…
Pepto-Bismol The Ultimate Solution for Five Common Digestive Issues Did you know that gastrointestinal (GI) issues affect a significant portion of the UK population each year? Research indicates that approximately 60% of adults in the UK experience some form of…
Cagent Vascular Announces the Launch of Serranator SL-PRO™ for Pedal and Tibial Disease Treatment Cagent Vascular a leader in the development of cutting-edge serration technology for vessel dilation in endovascular procedures, has unveiled its latest innovation: the Serranator SL-PRO™ PTA…
Reports Algiax Pharmaceuticals Announces Positive Phase 2a Results for AP-325 in Neuropathic Pain Reports Algiax Pharmaceuticals, a clinical-stage biotechnology company dedicated to developing innovative therapies for chronic neuropathic pain, has announced compelling topline results from its Reports Phase 2a proof-of-concept…
Cosette Pharmaceuticals a leading specialty pharmaceuticals company, has announced the appointment of Brad Leonard as Vice President, Generics Commercial Operations. This strategic move comes as the company continues its expansion in the generics market, reinforcing its commitment to leadership excellence…
Bayer has officially submitted a marketing authorization application to the European Medicines Agency (EMA), seeking approval for the use of finerenone in adult patients with heart failure (HF) with a left ventricular ejection fraction (LVEF) of 40% or greater. This…
Inhalon Biopharma a clinical-stage biotechnology company focused on developing innovative treatments for acute respiratory infections (ARI), has announced a major milestone in the advancement of its inhaled antibody platform. The company has successfully completed Investigational New Drug (IND)-enabling studies for…
